Soybean extracts (SBE) containing iso‰avone glycosides were cultured with Ganoderma lucidum mycelia producing b-glucosidase. The anti-angiogenic eŠects of the cultivated product, containing rich in genistein, named GCP (genistein combined polysaccharide), were assessed with chick chorioallantoic membranes (CAM) and a mouse dorsal air-sac model. b-Glucosidase produced by the mycelia converted the iso‰avone glycosides into aglycons. A test of volunteers showed that serum concentrations of genistein in the subjects treated with GCP (n＝4) at 3 h after administration were signiˆcant-ly higher than those in the subjects treated with SBE (n＝4).
Iso‰avones are found in nature in glycosylated form as a minor constituent of soybeans and other leguminous plants. It is generally thought that glycosides cannot be easily absorbed in the intestines. Iso‰avone glycosides are probably hydrolyzed in part by gastric acid 1) but they also undergo hydrolysis catalyzed by b-glucosidase produced by intestinal micro‰ora.
2) Iso‰avone aglycons are abundant in fermented soy products such as miso, nattou, and tempeh, fermented by Saccharomyces rouxii, Bacillus natto, and Rhizopus oligosporus, respectively. bglucosidase is widely distributed in microorganisms and plants, 3) and in some basidiomycete mushrooms (i.e., for Ganoderma lucidum, long been used in folk medicine for its anti-tumor activity arising from its polysaccharides). 4) Therefore, G. lucidum fermentation might convert iso‰avone glycosides to aglycons by its b-glucosidase activity. However, there has been no report about the fermentation of iso‰avone glycosides with G. lucidum.
Recently, the administration of soybean iso‰a-vones, especially genistein which is the aglycon form of genistin, was reported to be involved in the prevention of hormone-related cancers such as those of the breast and prostate. 5, 6) Genistein inhibits angiogenesis in vitro 7, 8) and in vivo, 9) and also tumor cell proliferation 7) and tumor growth in vivo. 10) Angiogenesis is the formation of new capillaries from existing blood vessels and is a fundamental process during embryonic development and in pathological conditions such as tumor growth and metastasis, diabetic retinopathy, and wound healing.
11) Genistein might be useful for cancer treatment because of its anti-angiogenic and antitumor activities.
In this study, toˆnd if G. lucidum mycelia would e‹ciently convert iso‰avone glycosides into aglycon and if the product obtained would help to prevent angiogenesis, soybean extracts (SBE) containing iso‰a-vone glycosides were cultured with b-glucosidaseproducing G. lucidum mycelia. The anti-angiogenic eŠects of the resulting product were assessed by chick chorioallantoic membranes (CAM) 12) and mouse dorsal air-sac model.
13)

Materials and Methods
Chemicals. Genistein, genistin, daidzein and daidzin were purchased from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Glycitein and glycitin samples were kindly provided by Dr. G. Nonaka of Usaien Co. (Saga, Japan). b-Glucosidase (produced from almonds) was purchased from the Oriental Yeast Co., Ltd. (Tokyo, Japan). p-Nitrophenyl-b-Dglucopyranoside was purchased from SigmaArdrich Fine Chemicals (St. Louis, MO). Other chemical agents were of analytical grade and were purchased from Wako (Osaka). Ganoderma lucidum (IFO 31863) was purchased from the Institute for Fermentation (Osaka).
Culture of soybean extracts with G. lucidum and production of Genistein Combined Polysaccharide (GCP). SBE containing about 40z iso‰avones (Novasoy) was purchased from Archer Daniels Midland Company (Decatur, IL). GCP was produced with a culture medium (pH＝5.6) contained 3.0z SBE, 1.0z malt extract, 0.125z yeast extract and 0.1z ammonium tartrate. G. lucidum mycelia were used to inoculate the medium, which was then cultured at 259 C on a rotary shaker at 130 rpm for 7-14 days. The culture was stopped when the conversion of genistin to genistein was almost complete because of the b-glucosidase produced by G. lucidum. The culture broth containing fermented SBE and G. lucidum mycelia was lyophilized. One milliliter of culture medium was collected and mixed with 1 ml of ethyl acetate to extract iso‰avone during the culture. The iso‰avone in the culture medium was measured by HPLC.
HPLC analysis of iso‰avones. Instrument components were purchased from Hitachi (Tokyo). Column: TSK-gel 80TM (Tosoh) reverse-phase C18, 100 Å (10 nm), 250×4.6 mm. The UV detector was set at 260 nm. Initial conditions were 10z acetonitrile:90z water containing 0.1z acetic acid, followed by a 40-min linear gradient to 40z acetonitrile containing 0.1z acetic acid.
Assay of b-glucosidase activity. The b-glucosidase activities of cultured G. lucidum mycelia were measured. The assay involved the addition of 1 ml of acetate buŠer (100 mM, pH 5.0) and 0.5 ml of pnitrophenyl-b-D-glucopyranoside (6.03 mg W ml, preheated at 379 C for 5 min) to 0.5 ml of the sample or standard b-glucosidase (about 0.01-0.02 IU W ml). After incubation of the solution at 379 C for 15 min, 2 ml of Na2CO3 solution (0.2 M) was added to stop the reaction. The absorption was measured at 400 nm.
Serum iso‰avone concentrations in humans treated with GCP or SBE. Eight healthy subjects (four men and four women aged 24 to 42 years old, with a mean body weight of 59.4 kg and SD of 13.9) were used to investigate the eŠects of a single oral dose of GCP and SBE. Informed consent was obtained from the subjects. At 9:00, subjects treated with GCP (n＝4) consumed 60 mg W kg body weight (13.2 mmol of a mixture of genistein and genistin W kg body weight) and subjects treated with SBE (n＝4) consumed 30 mg W kg body weight (11.1 mmol of a mixture of genistein and genistin W kg body weight). Venous blood samples (2 ml) were collected 0, 1, 3, 5, 7, and 24 h after consumption. Serum was obtained by centrifugation at 3000×g for 20 min at 49 C.
Serum samples were treated with b-glucuronidase (Sigma) to convert iso‰avone-glucuronate conjugates to the aglycon form. To 0.5 ml of the serum, 0.5 ml of acetate buŠer (100 mM, pH 5.0) and 30 ml of bglucuronidase solution were added. After incubation at 379 C for 1 h, 1 ml of ethyl acetate was added to extract iso‰avone. HPLC was done as described above.
Ex ovo angiogenesis assayed with chick chorioallantoic membranes (CAM). Fertilized chick eggs were incubated at 379 C and 60z humidity for three days. A small hole was made at the blunter end of the egg and 3 ml of egg white was withdrawn. Then the hole was sealed with tape (OpSite Incise, Smith & Nephew, Inc., Largo, FL). A 1.0×1.0 cm square window was cut on the opposite side and sealed with tape after the development of embryonic blood vessels was conˆrmed. The eggs were incubated similarly for another 3 days. GCP was suspended in phosphate-buŠered saline (PBS) at the concentration of 5z and the suspension (0.2 ml) or PBS (0.2 ml) was put to the eggs through the windows. Genistein was suspended in PBS at a concentration (3 mg W ml) similar to that of the GCP suspension. After incubation of the eggs for 2 days, the eggshell around the window was removed and the distribution of the blood vessels was photographed. The number of eggs with avascular zones, which were areas of capillary regression, on CAM divided by the total number of CAM was calculated.
In vivo angiogenesis caused by colon carcinoma cells in mice with implanted chambers. BALB W c mice and the colon-26 mouse colon carcinoma cell line were used. Filters were glued on both sides of rings (14-mm outer diameter, 10-mm inner diameter) with cement and let dry. The chamber wasˆlled by the injection of 0.2 ml (1×10 7 W ml) of a suspension of colon-26 cells in PBS. For the negative control, the chamber wasˆlled with PBS. The chambers were implanted subcutaneously into the back of the mice and the wound was closed with clips. Some mice were given GCP (0.3 g W day) orally once a day; others were not. After 5 days, the chamber was taken out and the distribution of vessels around the chamber was photographed and analyzed by NIH Image Ver. 1.61 (NIH, U.S.A). A threshold was set to segment each image into blood vessels and background on the basis of the gray level, and the pixels of blood vessel as a percentage of the entire image was calculated. The care and treatment of the animals in this study conformed to NIH guidelines.
Results
Conversion of iso‰avone glycosides to aglycons during culture with G. lucidum G. lucidum mycelia were cultured in the medium containing 3z iso‰avone extract for 14 days. , Genistein; , genistin; $, daidzein; #, daidzin; , pH. b-Glucosidase activity increased during the culture of G. lucidum mycelia at 9 days, activity was 84.1 mU W ml (Fig. 1). Figures 2 and 3 show the conversion of iso‰avone glycosides into aglycons during culture. The concentrations of these glycosides in the culture broth decreased and those of the corresponding aglycons increased during culture. The culture medium containing soybean extract was collected each day. The most abundant iso‰avones in the culture medium containing SBE were identiˆed as iso‰avone glycosides (Fig. 2(A) ). The iso‰avone aglycons genistein and daidzein were the most abundant in the medium after the culture as a result of G. lucidum fermentation (Fig. 2(B) ). The concentration of genistin in the culture broth was initially 5.98 mM and decreased to 0.004 mM at harvest. The concentration of genistein was initially 0.232 mM and increased to 5.11 mM (Fig. 3) . Table 1 shows the iso‰avone concentrations in GCP and SBE. The aglycons genistein, daidzein, and glycitein, comprised 98.5z of the iso‰avones of GCP. However in SBE, they were only about 6z of the iso‰avones of SBE. The iso‰avone content of the culture from G. lucidum was negligible.
Iso‰avone concentrations of GCP and SBE
Serum genistein concentration of humans treated with GCP Fig. 4 . Serum Genistein Concentrations in Humans Treated with GCP or SBE. Serum samples collected from humans given GCP (n＝4) or SBE (n＝4) were treated with b-glucuronidase and put through HPLC. DiŠerences between the groups were evaluated by Student's t-test (**pº0.01; *pº0.05). , Given GCP; , given SBE. Inhibitory ratio of CAM with avascular zones with the total CAM is examined. The number of CAM with avascular zones over the total number of CAM is indicated above each bar.
The genistein concentrations in serum in the subjects given GCP was 4.99±1.19 mM (mean±SD) 3 h after the administration, higher than in the subjects given SBE, 1.11±0.70 mM, ( pº0.01). The concentration of genistein was still high at 5 h (with GCP, 3.85±1.46; with SBE, 1.33±0.78 mM; pº0.05).
GCP inhibition of angiogenesis on CAM ex ovo
Six-day-old CAM had a rich vascular network (Fig. 5(A) ). Both large andˆne vessels were clear in the embryos treated with PBS. GCP, SBE, and genistein inhibited the ex ovo angiogenesis (Figs. 5(B) , 5(C), and 5(D)). The number of CAM with avascular zones divided by the total number of CAM is given above each column in Fig. 6 . Both treatments inhibited both formation of vessels of either size. Avascular zones were observed in all CAM treated with GCP or genistein, and avascular zones were observed in 36z of the embryos treated with SBE. No avascular zones were observed in the control treated with PBS.
EŠect of GCP on angiogenesis caused by carcinoma cells in vivo
The tumor cells in the chamber caused angiogenesis. New blood vessels were few in the PBS-ˆlled chamber. A few new vessels were present in the GCPtreated mice (Fig. 7) . GCP treatment decreased the ratio of pixels of blood vessels (Table 2) .
Discussion
Fermentation of soy increases the bioavailability of iso‰avone in soy because of hydrolysis by microorganisms. 14) Many reports refer to the deglycosylation of iso‰avone glycosides with fermentation by Lactobacillus casei, 15) biˆdobacterium, 16) and Rhizopus oryzae 17) through their b-glucosidase activities. G. lucidum can produce b-glucosidase.
4)
However, there is no study involving the deglycosylation of iso‰avone glycosides by basidiomycetes including G. lucidum. In this study, iso‰avone aglycons including genistein increased but iso‰avone glycosides including genistin decreased during fermentation with G. lucidum mycelia. The concentrations of iso‰avone aglycons rose with the increase of b-glucosidase activity. These results from quantitative analyses indicated that iso‰avone glycosides in SBE in the culture medium were gradually converted into corresponding aglycons through the action of the b-glucosidase produced by G. lucidum mycelia. Values are expressed means±SD (n＝3). The distribution of blood vessels around the chamber was photographed and analyzed by NIH Image.
Within the same row, means not sharing a common superscript are signiˆcantly diŠerent ( pº0.05). DiŠerences between the groups were evaluated by Tukey Multiple Comparison Test.
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Hessler et al. 18) have reported that fermentation with Saccharopolyspora erythroea, an organism that synthesizes erythromycin, produces genistein. However, the amount of genistein actually produced by fermentation was less than the amount of genistin calculated to be present in the soybean medium. They speculated that additional enzymatic biotransformations acted on genistein during the fermentation after its conversion from the glycoside form. In our study, the amount of genistein obtained was almost the same as the genistin that existed initially. Therefore, no additional biotransformation process was thought to be involved in this iso‰avone fermentation with G. lucidum. These results showed that the fermentation with G. lucidum e‹ciently converted iso‰avone glycosides into the corresponding aglycons.
Iso‰avone glycosides are not easily absorbed from the intestine without hydrolyzation by gastric acid or intestinal micro‰ora when consumed by humans. The result of a pharmacokinetic study of iso‰avone indicated that the rate-limiting step for absorption is the initial hydrolysis of the sugar moiety.
19) The iso‰avone glycosides are very poorly absorbed from the small intestine compared with aglycons, because the former have higher hydrophilicity and greater molecular mass than the latter.
1) Subjects treated with GCP had 4-fold the genistein concentration in the serum as compared to subjects treated with SBE. The higher concentration of genistein was observed at various times during monitoring. Iso‰avones in GCP were absorbed from the small intestine after fermentation with G. lucidum.
Some studies found an anti-angiogenesis eŠect of genistein both in vitro 7, 8) and in vivo. 9) Genistein inhibits angiogenesis in vitro, with the concentration of 150 mM giving half maximum inhibition. 8) A single oral dose of pure genistein (74 mmol W kg body weight) fed to rats resulted in a plasma genistein concentration of 11.0 mM at 2 h after the dose was given. 20) On the other hand, the maximum serum concentration of genistein in our study was 4.99 mM when genistein was administered as GCP in a dose of 13.1 mmol W kg. The concentration inhibits tumor cell proliferation in vivo, 7) although it probably does not inhibit angiogenesis. GCP inhibited angiogenesis caused by colon carcinoma cells in the mouse dorsal air-sac model in this study. The anti-angiogenesis study in vivo suggested that GCP contains other compounds, also causing the anti-angiogenesis, in addition to genistein.
In conclusion, we obtained GCP, a mixture containing iso‰avone aglycons and polysaccharides produced by G. lucidum mycelia, which was easily absorbed from the intestine and had anti-angiogenic activities ex ovo and in vivo. Because solid tumors do not grow without angiogenesis, GCP might prevent the growth of a wide variety of tumors. Genistein has multiple bioactivities including inhibition of tyrosine kinases and DNA repair topoisomerase. 21) 
